- Home
- FGBI vs CNTB Comparison
FGBI vs CNTB Comparison
Compare FGBI & CNTB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FGBI | CNTB |
|---|---|---|
| Founded | 1934 | 2012 |
| Country | United States | United States |
| Employees | 339 | N/A |
| Industry | Savings Institutions | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.1M | 128.6M |
| IPO Year | N/A | 2020 |
Fundamental Metrics
Financial Performance| Metric | FGBI | CNTB |
|---|---|---|
| Price | $8.70 | $2.52 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $8.50 |
| AVG Volume (30 Days) | 11.5K | ★ 88.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | ★ 0.45% | N/A |
| EPS Growth | N/A | ★ 75.22 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $26,033,000.00 |
| Revenue This Year | $567.70 | N/A |
| Revenue Next Year | N/A | $24,617.69 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.31 | $0.51 |
| 52 Week High | $10.55 | $3.28 |
Technical Indicators
Market Signals| Indicator | FGBI | CNTB |
|---|---|---|
| Relative Strength Index (RSI) | 49.66 | 49.32 |
| Support Level | $7.79 | $2.09 |
| Resistance Level | $8.72 | $2.86 |
| Average True Range (ATR) | 0.21 | 0.22 |
| MACD | -0.13 | -0.03 |
| Stochastic Oscillator | 17.57 | 21.25 |
Price Performance
Historical ComparisonAbout FGBI First Guaranty Bancshares Inc.
First Guaranty Bancshares Inc provides personalized commercial banking services to its customers in Louisiana, through several banking facilities. The principal business activity of the company includes attracting deposits and investing it together with funds generated from operations and borrowings insecurities and in lending activities to serve the credit needs of its customer base. The company offers commercial real estate loans, commercial and industrial loans, construction and land development loans, agricultural and farmland loans, and to a lesser extent, consumer and multifamily loans.
About CNTB Connect Biopharma Holdings Limited
Connect Biopharma Holdings Ltd is a clinical-stage company focused on the discovery and development of next-generation immune modulators for the treatment of serious autoimmune diseases and inflammation. It has leveraged its expertise in the biology of T cell modulation to build a portfolio of drug candidates consisting of small molecules and antibodies targeting critical pathways of inflammation. Its pipeline includes CBP-201, CBP-307 and CBP-174.